IP Library Granted Patent US 10,717,764
Granted Patent B2
US 10,717,764 · App. 16/427,691 · Granted Jul 21, 2020

Therapeutically active compounds and their methods of use

Inventors: Janeta Popovici-Muller (Windham, NH); Rene M. Lemieux (Charlestown, MA); Jeremy Travins (Southborough, MA); Zhenwei Cai (Skillman, NJ); Dawei Cui (Shanghai, CN); Ding Zhou (Shanghai, CN)
Assignee: Agios Pharmaceuticals, Inc.
C07K5/06078A61K38/005A61K38/05A61K45/06C07D205/08C07D207/26C07D401/04C07D401/14C07D403/04C07D413/04C07D417/04C07D401/12C07K5/06191
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,717,764
App. No.
16/427,691
Granted
Jul 21, 2020
Kind
B2
Abstract

Provided are methods of treating a cancer characterized by the presence of a mutant allele of IDH1/2 comprising administering to a subject in need thereof a compound described here.

Claims (3)

1. A method of treating cholangiocarcinoma characterized by the presence of an IDH1 mutation in a patient in need thereof comprising administering to the patient a therapeutically effective amount of (S)—N—((S)-1-(2-chlorophenyl)-2-((3,3-difluorocyclobutyl)amino)-2-oxoethyl)-1-(4-cyanopyridin-2-yl)-N-(5-fluoropyridin-3-yl)-5-oxopyrrolidine-2-carboxamide:

or a pharmaceutically acceptable salt or hydrate thereof.

2. The method of claim 1 wherein the IDH1 mutation is an IDH1 R132H or R132C mutation.

Assignments (6)
CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNEE NAME SERVIER PHARMACEUTICALS LLC BY REMOVAL OF COMMA AND UPDATING ZIP CODE TO 02210 PREVIOUSLY RECORDED ON REEL 056224 FRAME 0921. ASSIGNOR(S) HEREBY CONFIRMS THE CORRECTIVE ASSIGNMENT. Recorded Oct 28, 2021
From: AGIOS PHARMACEUTICALS, INC.
To: SERVIER PHARMACEUTICALS LLC
Reel/Frame 057970/0314 →
CORRECTIVE ASSIGNMENT TO CORRECT THE APPLICATION NO. 10,172,864 TO THE CORRECT APP NO. 61/160,253 PREVIOUSLY RECORDED ON REEL 056179 FRAME 0417. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded May 12, 2021
From: AGIOS PHARMACEUTICALS, INC.
To: SERVIER PHARMACEUTICALS, LLC
Reel/Frame 056224/0921 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 7, 2021
From: AGIOS PHARMACEUTICALS, INC.
To: SERVIER PHARMACEUTICALS, LLC
Reel/Frame 056179/0417 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 10, 2020
From: POPOVICI-MULLER, JANETA; LEMIEUX, RENE M.; TRAVINS, JEREMY
To: AGIOS PHARMACEUTICALS, INC.
Reel/Frame 052067/0315 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 10, 2020
From: CAI, ZHENWEI; CUI, DAWEI; ZHOU, DING
To: PHARMARESOURCES (SHANGHAI) CO., LTD.
Reel/Frame 052067/0403 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 10, 2020
From: PHARMARESOURCES (SHANGHAI) CO., LTD.
To: AGIOS PHARMACEUTICALS, INC.
Reel/Frame 052067/0417 →
Continuity (4)
Continuation 15809325 · Nov 10, 2017
Continuation 15279146 · Sep 28, 2016
Continuation 13745005 · Jan 18, 2013
Related Publication 20190315802A1 · Oct 17, 2019